Journal of Clinical Immunology & Immunotherapy Category: Clinical Type: Short Commentary

Protected Population Immunity, not a Vaccine, is the Way to Stop Covid-19 Pandemic

Richard Z Cheng1*
1 Cheng Integrative Health Center, 6149 St. Andrews Rd, Columbia, SC 29212, United States

*Corresponding Author(s):
Richard Z Cheng
Cheng Integrative Health Center, 6149 St. Andrews Rd, Columbia, SC 29212, United States
Tel:(803)233-3420,
Email:DrCheng@drwlc.com

Received Date: Apr 27, 2020
Accepted Date: May 20, 2020
Published Date: May 27, 2020

Abstract

New epidemics are on the rise. Due to the lengthy development of at least several years, vaccines are not effective of stopping or controlling new epidemics. Herd immunity, we prefer the term population immunity (as the term herd generally implies animals other than humans) may be the only way to stop an ongoing new epidemic.  However, unprotected exposure of the public to new pathogens (viruses) may result in high morbidity, mortality and economic losses. It may also seem irresponsible or unethical for governments not to offer any protection to its citizens. Early and sufficient use of vitamin C (along with vit D3, zinc, magnesium etc) is able to offer a high level of protection.  A strategy of combining supplements of vitamin C and other nutrients with traditional herd immunity to form the basis of the "Protected Population Immunity" is worth further study and may become a better preventive measure to stop Covid-19 and future epidemics.

EPIDEMICS/PANDEMICS ARE ON THE RISE

In a short period of only 4 months, Covid-19 pandemic has caused more than~200,000 fatalities, with 2.7 million confirmed cases of SARS-Cov-2 infections, and economic losses in the trillions of USD worldwide.

An article on Wall Street Journal’s Economy section on March 6, 2020, read “Global viral outbreaks like Coronavirus, once rare, will become more common” [1]. BBC also reported on March 25, 2020 (Covid-19: the history of pandemics) that the rate of new epidemics like SARS, MERS and Covid-19 has increased 4-fold over the past century. The annual outbreak of epidemics in the last 40 years has doubled [2]. On the List of Epidemics entry of Wikipedia, in the short 20 years of the 21st century, there has been over 60 epidemics compared to the less than 100 epidemics in the entire 19th and 20th centuries combined. This is about a 650% annual increase in the number of epidemics in the last 20 years compared to the 200 years prior! Moreover, there have been 11 epidemics in the 21st century that caused more than 1,000 fatalities, compared to the 14 epidemics in the 200 years prior. If we use fatality of 1,000 as a marker for severity, there has been an increase of 785% [3].

WHAT’S THE PLAN OF OUR GOVERNMENTS, THE WORLD HEALTH ORGANIZATION, THE PHARMACEUTICAL INDUSTRY, AND THE LEADING MEDICAL INSTITUTIONS TO DEAL WITH DISTURBING TREND OF INCREASING EPIDEMICS?

Probably the most common term used to describe prevention of epidemics is "vaccine." International agencies like WHO, sovereign governments, major foundations, pharmaceutical industry, as well as leaders in major medical institutions appear to be all focused on vaccine and vaccine only.

We wish we had a Covid-19 vaccine today. We wish we had a Covod-19 vaccine 4 months ago. But unfortunately, we didn’t had we don’t.  The best estimate of a vaccine is at least 18-24 months away, if possible at all.

VACCINE IS NOT AN IDEAL ANSWER TO NEW EPIDEMICS

The nature of vaccine development makes vaccine strategy against new epidemics a less than ideal one. Let’s look at the process of how a vaccine is developed.

First, a new pathogen (e.g., SARS-Cov-2 virus that causes Covid-19 pandemic) appears and causes a local infectious disease outbreak. This eventually catches the attention of the local medical agencies and governments. Scientists then begin to study the new infectious disease, identify the new pathogen, develop a vaccine, which needs to go through clinical trials to demonstrate its safety and effectiveness. If the clinical trial is successful, an application for approval by the FDA is then submitted.  If a vaccine is finally approved by the FDA, then it is then mass produced and distributed for clinical use. This is a lengthy process, with at least 2-3 years after a new epidemic breaks out. To make things worse, due the frequent mutations of viruses, especially for RNA viruses, and due to the delay in finally mass-producing a vaccine, the virus has likely mutated to lower the vaccine's efficacy [4].

Covid-19 has already caused nearly~200,000 deaths and trillions of dollars in economic damage in a short period of 4 months. The best estimate for a vaccine is still 1.5-2 year away. Likely many more lives and much more economic damage will occur in the next 18 to 24 months while we are waiting and expecting a vaccine. What if we will never see an effective vaccine? , In the history of medicine, there has never been a vaccine developed in a timely manner to stop an ongoing new epidemic. Successful vaccines today are only effective against an existing infectious disease or recurrent epidemic, not a new epidemic. Even so, for most of the many recent epidemics like SARS, MERS, Ebola, Marburg, Zika, and Dengue, to name just a few, there is no vaccine. Further, vaccines can only prevent an infection.  Vaccines are not treatment for infections.

IDEAL PREVENTIVE AND TREATMENT MEASURES AGAINST ALL EPIDEMICS, BOTH NEW AND RECURRENT, ARE URGENTLY NEEDED

We clearly need better preventive and treatment measures to deal with the disturbingly increasing trend of epidemics. Ideally good preventive and treatment measures for new epidemics should have the following characteristics:

  1. Nonpathogen specific and universal: treatments that can lower the risk of infection from a virus or other pathogens, or can reduce the severity of the infection. This characteristic would allow us to prevent and treat any epidemic when it occurs, without any unnecessary delay.
  2. Effective and safe.
  3. Readily available: when an epidemic breaks out, we need to have it available right away to stop an epidemic.
  4. Affordable: This is yet another key characteristic for large scale application to stop an ongoing epidemic.

For new epidemics, vaccines clearly don’t meet the above criteria.

OUR NATURAL DEFENSE MECHANISMS INCLUDING NUTRIENTS LIKE VITAMIN C ARE AMONG THE FEW OPTIONS THAT MEET THE ABOVE CHARACTERISTICS. THEY CAN DEFEND US FROM CATCHING DISEASES, OR CAN PREVENT THE DISEASE FROM PROGRESSION. OTHER SUCH NUTRIENTS INCLUDE VITAMIN D3, ZINC, MAGNESIUM, SELENIUM ETC.

Vitamin C

Vitamin C has pleiotropic biological effects including but not limited to its antiviral and antimicrobial effects, immune-boosting effects, as well as antioxidant effects.

  1. Vitamin C has potent antiviral effects through virucidal and immune modulating effects [5-14].
  2. Vitamin C is a prototypical potent antioxidant that plays a critical role in the prevention and treatment of marked inflammatory response to virus or other pathogens. Clinically vitamin C is effective in preventing and treating pneumonia [13], multi-organ failure [15], and acute respiratory distress syndrome (ARDS) [4,16,17].
  3. Preliminary clinical evidence from China and elsewhere seems to show high-dose IV vitamin C is effective in treating Covid-19 patients [18,19].
  4. Out of the few treatments being tried for Covid-19, high-dose intravenous Vitamin C (HDIVC) shows very promising results in treating critical cases of Covid-19 with reduced fatalities, reduced ICU or hospital stays [20-23]. and is very safe, without significant side effects [24]. HDIVC’s effectiveness in treating infectious (including viral) diseases and its high safety profile is based on solid science with decades of basic and clinical research reflected in tens of thousands of research papers in world’s largest biomedical library, the United States National Library of Medicine, hosted at the NIH (pubmed.gov).
  5. Given the lack of proven and widely accepted effective treatments of Covid-19, the high safety profile of HDIVC and promising effectiveness of HDIVC makes the compassionate use of HDIVC very reasonable. In my opinion, not to give HDIVC to critically ill Covid-19 patients seems unthinkable or may even be unethical.

PROTECTED POPULATION IMMUNITY

With vaccines against Covid-19 not anywhere near, the only other hope to stop the Covid-19 pandemic seems to be population immunity -- when enough members of a population develop immunity against SARS-Cov-2 virus.

But to leave the public without any protection from the risk of a SARS-Cov-2 infection seems cruel, unethical and may even cause a public outcry.

However, with sufficient doses of vitamin C (3000 mg/d in divided doses, and other nutrients such as vitamin D3 (2000-5000IU/d), zinc (20 mg/d), magnesium (400 mg/d), to name a few) should lower the risk of the public developing the infection, and can protect patients in the initial stages of infection from progressing to more serious disease [20]. Vitamins C and D are known to assist and empower the immune system to prevent viral infection [20-28], and vitamin C in high oral doses (to bowel tolerance)) [29,30] can denature viruses and prevent damage to the body from oxidative stress.  Supplemental high-dose oral or intravenous vitamin C is indicated in severe infections and oxidative stress because they cause the vitamin C level to drop to zero [25]. Zinc and magnesium are known anti-viral agents [28]. [[need references on prevention with vit C, D, zinc, and magnesium]] With such a treatment that has worked to prevent serious infection of a variety of other viruses, further research is clearly indicated here. When proven, this strategy not only can help stop Covid-19 pandemic, it will also protect us in the future epidemics.

ACKNOWLEDGEMENT

Thanks to the members of the editorial board of Orthomolecular Medicine News Service who reviewed and critiqued this manuscript, including the choice of “population immunity” over “herd immunity”.

REFERENCES

  1. Hilsenrath J (2020) Global viral outbreaks like coronavirus, once rare, will become more common. Wall Street Journal.
  2. https://www.bbc.com/future/article/20200325-covid-19-the-history-of-pandemics.
  3. https://en.wikipedia.org/wiki/List_of_epidemics.
  4. Kashiouris MG, L'Heureux M, Cable CA, Fisher BJ, Leichtle SW, et al. (2020) The Emerging Role of Vitamin C as a Treatment for Sepsis. Nutrients 12: 292.
  5. Pauling L (1971) The Significance of the Evidence about Ascorbic Acid and the Common Cold. Proc Natl Acad Sci U S A 68: 2678-2681.
  6. Chen Q, Espey MG, Krishna MC, Mitchell JB, Corpe CP, et al. (2005) Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci U S A 102: 13604-13609.
  7. Chen Q, Espey MG, Sun AY, Lee JH, Krishna MC, et al. (2007) Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc Natl Acad Sci U S A 104: 8749-8754.
  8. Du J, Martin SM, Levine M, Wagner BA, Buettner GR, et al. (2010) Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer. Clin Cancer Res 16: 509-520.
  9. Sestili P, Brandi G, Brambilla L, Cattabeni F, Cantoni O (1996) Hydrogen peroxide mediates the killing of U937 tumor cells elicited by pharmacologically attainable concentrations of ascorbic acid: Cell death prevention by extracellular catalase or catalase from cocultured erythrocytes or fibroblasts. J. Pharmacol Exp Ther 277: 1719-1725.
  10. Verrax J, Calderon PB (2009) Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects. Free Radic Biol Med 47: 32-40.
  11. Hemila H, Chalker E (2013) Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev 31: CD000980.
  12. Nabzdyk CS, Bittner EA (2018) Vitamin C in the critically ill-indications and controversies. World J Crit Care Med 7: 52-61.
  13. Hemila H (2017) Vitamin C and Infections. Nutrients 9: 339.
  14. Colunga Biancatelli RML, Berrill M, Marik PE (2020) The antiviral properties of vitamin C. Expert Rev Anti Infect Ther 18: 99-101.
  15. Vincent JL, Moreno R, Takala J, Wilatts S, Mendonca A, et al. (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22: 707-710.
  16. Sawyer M, Mike J, Chavin K (1989) Antioxidant therapy and survival in ARDS (abstract). Crit Care Med 17: S153.
  17. Marik PE, Khangoora V, Rivera R, Hooper MH, Catravas J (2017) Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study. Chest 151: 1229-1238.
  18. http://www.drwlc.com/blog/2020/04/16/video-conference-with-dr-zy-peng-of-the-worlds-first-high-dose-ivc-trial/.
  19. Cheng RZ (2020) Can early and high intravenous dose of vitamin C prevent and treat coronavirus disease 2019 (COVID-19)? Medicine in Drug Discovery 5: 100028.
  20. http://orthomolecular.org/resources/omns/v16n21.shtml
  21. Player G, Saul AW, Downing D, Schuitemaker G (2020) Published Research and Articles on Vitamin C as a Consideration for Pneumonia, Lung Infections, and the Novel Coronavirus (SARS-CoV-2/COVID-19) Orthomolecular Medicine News Service.
  22. Front Line COVID Critical Care Group (2020) Early Intervention Protocol for COVID-19 Can Save Lives.
  23. Carr AC, Maggini S (2017) Vitamin C and Immune Function. Nutrients 9: 1211.
  24. Prier M, Carr A, Baillie N (2018) No reported renal stones with intravenous vitamin C administration: A prospective case series study. Antioxidants (Basel) 7: 68.
  25. Berger MM (2009) Vitamin C Requirements in Parenteral Nutrition. Gastroenterology 137: S70-78.
  26. Grant WB, Baggerly CA (2020) Vitamin D Supplements Could Reduce Risk of Influenza and COVID-19 Infection and Death. Orthomolecular Medicine News Service.
  27. Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, et al. (2020) Evidence That Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients 12: E988.
  28. Gombart AF, Pierre A, Maggini S (2020) A review of micronutrients and the immune system-working in harmony to reduce the risk of infection. Nutrients 12: 236.
  29. Cathcart RF (1981) Vitamin C, titrating to bowel tolerance, anascorbemia, and acute induced scurvy. Medical hypotheses 7: 1359-1376.
  30. http://orthomolecular.org/library/jom/2005/pdf/2005-v20n04-p237.pdf

Citation: Cheng RZ (2020) Protected Population Immunity, not a Vaccine, is the Way to Stop Covid-19 Pandemic. J Clin Immunol Immunother 6: 025.

Copyright: © 2020  Richard Z Cheng, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

© 2022, Copyrights Herald Scholarly Open Access. All Rights Reserved!